Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of AEG35156 Administered by 2-Hour Intravenous Infusion in Patients With Advanced Cancers

NCT00385775 is registered in ClinicalTrials.gov with Aegera Therapeutics as lead sponsor.

NCT NCT00385775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00385775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of AEG35156 Administered by 2-Hour Intravenous Infusion in Patients With Advanced Cancers
Lead sponsor
Aegera Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2006
Completion date
November 30, 2008
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer